Byvalson Side Effects

Generic name: nebivolol / valsartan

Medically reviewed by Drugs.com. Last updated on May 24, 2023.

Note: This document contains side effect information about nebivolol / valsartan. Some dosage forms listed on this page may not apply to the brand name Byvalson.

Applies to nebivolol / valsartan: oral tablet.

Serious side effects of Byvalson

Along with its needed effects, nebivolol / valsartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking nebivolol / valsartan:

Incidence not known

• Blurred vision
• chest pain or tightness
• confusion
• decreased urine output
• difficult breathing
• dilated neck veins
• dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
• extreme fatigue
• irregular breathing
• irregular heartbeat
• nausea or vomiting
• nervousness
• numbness or tingling in the hands, feet, or lips
• stomach pain
• sweating
• swelling of the face, fingers, feet, or lower legs
• trouble breathing
• unusual tiredness or weakness
• weakness or heaviness of the legs
• weight gain

For Healthcare Professionals

Applies to nebivolol / valsartan: oral tablet.

Cardiovascular

Frequency not reported: Hypotension

Nebivolol:

Postmarketing reports: Atrioventricular block (both second and third degree), myocardial infarction, Raynaud's phenomenon, peripheral ischemia/claudication

Valsartan:

Postmarketing reports: Vasculitis^[Ref]

Dermatologic

Rare (0.01% to 0.1%): Angioedema

Nebivolol:

Postmarketing reports: Pruritus, psoriasis, various rashes, various skin disorders, urticaria, allergic vasculitis

Valsartan:

Postmarketing reports: Angioedema, alopecia, bullous dermatitis^[Ref]

Gastrointestinal

Postmarketing reports: Vomiting^[Ref]

Genitourinary

Postmarketing reports: Erectile dysfunction

Nebivolol:

Postmarketing reports: Thrombocytopenia

Valsartan:

Postmarketing reports: Thrombocytopenia^[Ref]

Hepatic

Nebivolol:

Postmarketing reports: Abnormal hepatic function (including increased AST, ALT, and bilirubin)

Valsartan:

Postmarketing reports: Elevated liver enzymes, hepatitis

Valsartan:

Postmarketing reports: Angioedema^[Ref]

Metabolic

Common (1% to 10%): Hyperkalemia

Valsartan:

Postmarketing reports: Hyperkalemia^[Ref]

Nervous system

Postmarketing reports: Somnolence, syncope, vertigo

Nebivolol:

Postmarketing reports: Acute renal failure

Valsartan:

Postmarketing reports: Impaired renal function, renal failure^[Ref]

Respiratory

Nebivolol:

Postmarketing reports: Acute pulmonary edema, bronchospasm^[Ref]

Frequently asked questions

• What is Byvalson used for?

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer